These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 11723116

  • 1. Regulation of cGMP-specific phosphodiesterase (PDE5) phosphorylation in smooth muscle cells.
    Rybalkin SD, Rybalkina IG, Feil R, Hofmann F, Beavo JA.
    J Biol Chem; 2002 Feb 01; 277(5):3310-7. PubMed ID: 11723116
    [Abstract] [Full Text] [Related]

  • 2. Individual cerebellar Purkinje cells express different cGMP phosphodiesterases (PDEs): in vivo phosphorylation of cGMP-specific PDE (PDE5) as an indicator of cGMP-dependent protein kinase (PKG) activation.
    Shimizu-Albergine M, Rybalkin SD, Rybalkina IG, Feil R, Wolfsgruber W, Hofmann F, Beavo JA.
    J Neurosci; 2003 Jul 23; 23(16):6452-9. PubMed ID: 12878685
    [Abstract] [Full Text] [Related]

  • 3. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
    Murthy KS.
    Biochem J; 2001 Nov 15; 360(Pt 1):199-208. PubMed ID: 11696008
    [Abstract] [Full Text] [Related]

  • 4. Phosphorylation of phosphodiesterase-5 by cyclic nucleotide-dependent protein kinase alters its catalytic and allosteric cGMP-binding activities.
    Corbin JD, Turko IV, Beasley A, Francis SH.
    Eur J Biochem; 2000 May 15; 267(9):2760-7. PubMed ID: 10785399
    [Abstract] [Full Text] [Related]

  • 5. ANF elicits phosphorylation of the cGMP phosphodiesterase in vascular smooth muscle cells.
    Wyatt TA, Naftilan AJ, Francis SH, Corbin JD.
    Am J Physiol; 1998 Feb 15; 274(2):H448-55. PubMed ID: 9486247
    [Abstract] [Full Text] [Related]

  • 6. The regulation of the cGMP-binding cGMP phosphodiesterase by proteins that are immunologically related to gamma subunit of the photoreceptor cGMP phosphodiesterase.
    Lochhead A, Nekrasova E, Arshavsky VY, Pyne NJ.
    J Biol Chem; 1997 Jul 18; 272(29):18397-403. PubMed ID: 9218482
    [Abstract] [Full Text] [Related]

  • 7. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
    Mullershausen F, Lange A, Mergia E, Friebe A, Koesling D.
    Mol Pharmacol; 2006 Jun 18; 69(6):1969-74. PubMed ID: 16510560
    [Abstract] [Full Text] [Related]

  • 8. Allosteric sites of phosphodiesterase-5 (PDE5). A potential role in negative feedback regulation of cGMP signaling in corpus cavernosum.
    Gopal VK, Francis SH, Corbin JD.
    Eur J Biochem; 2001 Jun 18; 268(11):3304-12. PubMed ID: 11389733
    [Abstract] [Full Text] [Related]

  • 9. Differential expression of multidrug resistance protein 5 and phosphodiesterase 5 and regulation of cGMP levels in phasic and tonic smooth muscle.
    Al-Shboul O, Mahavadi S, Sriwai W, Grider JR, Murthy KS.
    Am J Physiol Gastrointest Liver Physiol; 2013 Aug 15; 305(4):G314-24. PubMed ID: 23764893
    [Abstract] [Full Text] [Related]

  • 10. Expression, distribution and regulation of phosphodiesterase 5.
    Lin CS, Lin G, Xin ZC, Lue TF.
    Curr Pharm Des; 2006 Aug 15; 12(27):3439-57. PubMed ID: 17017938
    [Abstract] [Full Text] [Related]

  • 11. Specific cGMP binding by the cGMP binding domains of cGMP-binding cGMP specific phosphodiesterase.
    Liu L, Underwood T, Li H, Pamukcu R, Thompson WJ.
    Cell Signal; 2002 Jan 15; 14(1):45-51. PubMed ID: 11747988
    [Abstract] [Full Text] [Related]

  • 12. Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling.
    Mullershausen F, Friebe A, Feil R, Thompson WJ, Hofmann F, Koesling D.
    J Cell Biol; 2003 Mar 03; 160(5):719-27. PubMed ID: 12604588
    [Abstract] [Full Text] [Related]

  • 13. PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.
    Rybalkin SD, Rybalkina IG, Shimizu-Albergine M, Tang XB, Beavo JA.
    EMBO J; 2003 Feb 03; 22(3):469-78. PubMed ID: 12554648
    [Abstract] [Full Text] [Related]

  • 14. Contractile agonists attenuate cGMP levels by stimulating phosphorylation of cGMP-specific PDE5; an effect mediated by RhoA/PKC-dependent inhibition of protein phosphatase 1.
    Murthy KS.
    Br J Pharmacol; 2008 Mar 03; 153(6):1214-24. PubMed ID: 18204475
    [Abstract] [Full Text] [Related]

  • 15. Augmentation of cGMP/PKG pathway and colonic motility by hydrogen sulfide.
    Nalli AD, Bhattacharya S, Wang H, Kendig DM, Grider JR, Murthy KS.
    Am J Physiol Gastrointest Liver Physiol; 2017 Oct 01; 313(4):G330-G341. PubMed ID: 28705807
    [Abstract] [Full Text] [Related]

  • 16. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.
    Kim D, Aizawa T, Wei H, Pi X, Rybalkin SD, Berk BC, Yan C.
    J Mol Cell Cardiol; 2005 Jan 01; 38(1):175-84. PubMed ID: 15623434
    [Abstract] [Full Text] [Related]

  • 17. Cyclic GMP phosphodiesterases and regulation of smooth muscle function.
    Rybalkin SD, Yan C, Bornfeldt KE, Beavo JA.
    Circ Res; 2003 Aug 22; 93(4):280-91. PubMed ID: 12933699
    [Abstract] [Full Text] [Related]

  • 18. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I, Del Mese P, Doronzo G, Mattiello L, Viretto M, Bosia A, Anfossi G, Trovati M.
    Endocrinology; 2008 Apr 22; 149(4):1480-9. PubMed ID: 18079207
    [Abstract] [Full Text] [Related]

  • 19. cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5.
    Kotera J, Grimes KA, Corbin JD, Francis SH.
    Biochem J; 2003 Jun 01; 372(Pt 2):419-26. PubMed ID: 12617722
    [Abstract] [Full Text] [Related]

  • 20. Partial reconstitution of photoreceptor cGMP phosphodiesterase characteristics in cGMP phosphodiesterase-5.
    Granovsky AE, Artemyev NO.
    J Biol Chem; 2001 Jun 15; 276(24):21698-703. PubMed ID: 11285263
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.